ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's, Lupin recall products in US due to manufacturing issues: USFDA
Dr Reddy's Laboratories and Lupin are recalling products in the US due to manufacturing issues, as per the US Food and Drug Administration (USFDA). Dr Reddy's Laboratories Inc, a subsidiary of Hyderabad-based drug firm, is recalling Ibuprofen tablets in mu
Announcement as on 04 September 2024

Dr Reddy's gets establishment inspection report from USFDA for Visakhapatnam units
Dr Reddy's Laboratories Ltd has obtained an Establishment Inspection Report from the USFDA for its Duvvada units, now classified as Voluntary Action Indicated. The units underwent an inspection from May 8 to May 17, 2024, which led to a Form 483 with obser
Announcement as on 12 August 2024

Market Trading Guide: Tata Power, Dr Reddy's Labs among 6 stock recommendations for Friday
Indian benchmarks hit record highs on Thursday, driven by expectations of a U.S. interest rate cut. The Sensex rose 0.15% to 81,867, while the Nifty50 stayed above 25,000.
Announcement as on 01 August 2024

Dr Reddy's Laboratories consolidated net profit declines 0.90% in the June 2024 quarter
Sales rise 13.87% to Rs 7672.70 crore
Announcement as on 27 July 2024

Dr Reddy's Laboratories Q1 result: Net profit dips 0.90%, revenue up 13.88%
DRL's growth was primarily driven by the robust performance of the global generics business, particularly in North America and India
Announcement as on 27 July 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.21
  • 12Day Average: 12.02
  • 20Day Average: 12.07
  • 50Day Average: 13.07
  • 100Day Average: 13.24
  • 150Day Average: 13.48
  • 200Day Average: 13.59

RDY Indicators & signals

Indicator MACD (12,26,9)

12.16, 12.42, -0.38
Indicator MACD is in negative zone

Indicator ADX (14)

14.29, 27.27, 36.36
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
11 Tue Aug 2026 12.45 12.42 to 12.58 2.47% 0.89 times
10 Mon Aug 2026 12.15 11.58 to 12.29 -0.57% 0.74 times
07 Fri Aug 2026 12.22 12.12 to 12.26 0.91% 0.96 times
06 Thu Aug 2026 12.11 12.05 to 12.22 -0.25% 0.96 times
05 Wed Aug 2026 12.14 12.13 to 12.24 0.33% 0.94 times
04 Tue Aug 2026 12.10 11.97 to 12.21 0.25% 0.77 times
03 Mon Aug 2026 12.07 11.95 to 12.14 1.86% 1.31 times
31 Fri Jul 2026 11.85 11.72 to 11.86 0.17% 1.12 times
30 Thu Jul 2026 11.83 11.75 to 11.87 0.6% 0.79 times
29 Wed Jul 2026 11.76 11.75 to 11.87 0.26% 0.87 times
28 Tue Jul 2026 11.73 11.60 to 11.89 -0.34% 1.55 times
27 Mon Jul 2026 11.77 11.70 to 11.88 -0.17% 1.35 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top